INMED

AcronymDefinition
INMEDInternational Medical Services for Health (Ashburn, VA)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Adams will present an update on InMed's recent progress on several programs, including plans for the INM-755 program for Epidermolysis Bullosa, the status of the glaucoma program with INM-088 (previously INM-085), the biosynthesis manufacturing program, as well as other general corporate updates.
Colwill joins InMed with more than 25 years of experience in financial leadership roles.
A key focus area of our corporate social investment projects is the countrys youth and our partnership with INMED has provided us with the opportunity to educate, empower and add value to the lives of our children.
Furthermore, it will improve the companya[euro](tm)s footprint in the oil and gas markets.Country: UKSector: ElectronicsTarget: Wellman Defence Ltd, Wellman Hunt Graham LtdBuyer: Corac Group plcVendor: InMed Ventures LimitedDeal size in USD: 16.8mComment: The deal size is combined and includes discharge of liabilities.
Adams, President and Chief Executive Officer of InMed, said, 'We are excited to attend the 2nd Annual iCDP conference, and are proud that two members of our executive team have been selected as panelists.' Mr.
Dr Hossain said, 'InMed's continued success in developing cannabinoids to treat serious diseases is vital to me.
Colwill joins InMed with over 25 years of experience in financial leadership roles.
InMed Pharmaceuticals is specialising in the research and development of novel, cannabinoid-based prescription drug therapies utilising novel drug delivery systems.
Hsu joins InMed with more than 18 years of scientific leadership experience in developing novel gene transfer technologies and validation of preclinical drug candidates.
Biopharmaceutical company InMed Pharmaceuticals Inc (CSE:IN)(OTCQB:IMLFF) revealed on Monday the launch of a cannabinoid based research and development collaboration with ATERA SAS to produce human tissue models of specific diseases.